StockNews.AI
TXG
StockNews.AI
203 days

10x Genomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 12, 2025

1. 10x Genomics will report Q4 and full year results on February 12, 2025. 2. Financial performance may directly impact TXG's stock price.

Earnings
0%Current Return
VS
-0.43%S&P 500
$14.8401/28 04:07 PM EDTEvent Start
$14.8401/29 10:38 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Neutral?

Earnings reports can correlate with stock performance but are uncertain in outcome; past reports showed varied reactions in biotech stocks.

How important is it?

Earnings results are a critical indicator for investor expectations and company performance.

Why Short Term?

The upcoming earnings report typically influences immediate investor sentiment and stock price movement.

Related Companies

TXG
PLEASANTON, Calif. , Jan. 28, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the fourth quarter and full year ended December 31, 2024 after market close on Wednesday, February 12, 2025.

Related News